These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 17499452
1. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer. Wahlgren T, Nilsson S, Lennernäs B, Brandberg Y. Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):662-70. PubMed ID: 17499452 [Abstract] [Full Text] [Related]
2. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25. Wahlgren T, Brandberg Y, Häggarth L, Hellström M, Nilsson S. Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):51-9. PubMed ID: 15337539 [Abstract] [Full Text] [Related]
3. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life. Roeloffzen EM, Hinnen KA, Battermann JJ, Monninkhof EM, van Roermund JG, van Gellekom MP, Frank SJ, van Vulpen M. Int J Radiat Oncol Biol Phys; 2010 Aug 01; 77(5):1322-8. PubMed ID: 19939578 [Abstract] [Full Text] [Related]
4. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer. Roeloffzen EM, Lips IM, van Gellekom MP, van Roermund J, Frank SJ, Battermann JJ, van Vulpen M. Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1054-60. PubMed ID: 20097486 [Abstract] [Full Text] [Related]
5. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F, Multicentric Spanish Group of Clinically Localized Prostate Cancer. Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):421-32. PubMed ID: 18325680 [Abstract] [Full Text] [Related]
6. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Galalae RM, Loch T, Riemer B, Rzehak P, Küchler T, Kimmig B, Kovács G. Strahlenther Onkol; 2004 Sep 01; 180(9):582-9. PubMed ID: 15378189 [Abstract] [Full Text] [Related]
7. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, Wei JT. J Clin Oncol; 2005 Apr 20; 23(12):2772-80. PubMed ID: 15837992 [Abstract] [Full Text] [Related]
8. 3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey. Vordermark D, Wulf J, Markert K, Baier K, Kölbl O, Beckmann G, Bratengeier K, Noe M, Schön G, Flentje M. Acta Oncol; 2006 Apr 20; 45(6):708-16. PubMed ID: 16938814 [Abstract] [Full Text] [Related]
9. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients. Wahlgren T, Levitt S, Kowalski J, Nilsson S, Brandberg Y. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):997-1004. PubMed ID: 20932681 [Abstract] [Full Text] [Related]
10. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Feigenberg SJ, Lee WR, Desilvio ML, Winter K, Pisansky TM, Bruner DW, Lawton C, Morton G, Baikadi M, Sandler H. Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):956-64. PubMed ID: 15989995 [Abstract] [Full Text] [Related]
11. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy. Staff I, Salner A, Bohannon R, Panatieri P, Maljanian R. Cancer; 2003 Dec 01; 98(11):2335-43. PubMed ID: 14635067 [Abstract] [Full Text] [Related]
12. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. J Natl Cancer Inst; 2004 Sep 15; 96(18):1358-67. PubMed ID: 15367568 [Abstract] [Full Text] [Related]
13. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy. Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, Yoshimura K, Numata I, Satoh M, Saito S, Takai Y, Yamada S, Arai Y. Jpn J Clin Oncol; 2006 Apr 15; 36(4):224-30. PubMed ID: 16537689 [Abstract] [Full Text] [Related]
14. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. Lee WR, McQuellon RP, Case LD, deGuzman AF, McCullough DL. J Urol; 1999 Aug 15; 162(2):403-6. PubMed ID: 10411047 [Abstract] [Full Text] [Related]
15. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP. J Urol; 2003 Nov 15; 170(5):1822-7. PubMed ID: 14532784 [Abstract] [Full Text] [Related]
16. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls. Fransson P. Acta Oncol; 2008 Nov 15; 47(5):852-61. PubMed ID: 17899451 [Abstract] [Full Text] [Related]
17. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy. Yang BK, Crisci A, Young MD, Silverstein AD, Peterson BL, Dahm P. Urology; 2005 Jan 15; 65(1):120-5. PubMed ID: 15667876 [Abstract] [Full Text] [Related]
18. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer. Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M. Jpn J Clin Oncol; 2008 Jul 15; 38(7):480-5. PubMed ID: 18621847 [Abstract] [Full Text] [Related]
19. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. J Natl Cancer Inst; 2009 Jun 16; 101(12):888-92. PubMed ID: 19509365 [Abstract] [Full Text] [Related]
20. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy. Homs MY, Essink-Bot ML, Borsboom GJ, Steyerberg EW, Siersema PD, Dutch SIREC Study Group. Eur J Cancer; 2004 Aug 16; 40(12):1862-71. PubMed ID: 15288288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]